|
|
|
|
|
Beauvage Eye Contour Lift
Proffessional Strength Eye Care with Naturally Active ingredients in an Ultra Light Serum.
Loaded with 4 Peptides: Acetyl Hexapeptide-3, Palmitoyl Oligopeptide,Palmitoyl Pentapeptide-3, Eyeliss and Haloxyl. Removes dark circles, Eliminates puffiness around eyes Firms bags under eyes, Smooths wrinkles & lines. Hydrates the eye area In a 15ml prepump bottle!
An oil free Eye Serum for alleviating dark circles and puffiness from around the eyes. Vanishes crow’s feet and the dreaded double lines between the eyebrows. No flakiness or tacky residue when dry. Specific actives have been added to this serum that reduce the dark rings from under the eyes. The cosmetic properties have PAL-GHK and PAL-GQPR, which reinforces firmness and tone around the eye area. Chrysin, Eyeliss (This patented and trademarked ingredient contains three active ingredients, namely Hesperidin methyl Chalcone, dipeptide Valyl-Tryptophane and lipopeptide Pal-Cly-Gln-Pro-Arg.), Haloxyl (lessens under eye dark circles), and N-Hydroxysuccinimide promotes the elimination of blood originating pigments from under the eyes. These blood pigments are responsible for the dark circles. For maximum benefits please use twice per day and will get better with continued use. Light yellow in colour with all natural ingredients, no colour or fragrance has been added. We never test on animals. Can be applied to top of eye lids & under eyes Apply morning & evening around delicate eye areas Can be worn under make-up A brightening eye treatment Helps vanish wrinkles & lines. Fades dark circles, and firms sagging skin Instantly improves blood circulation. Gently firms skin while hydrating Soothes away puffiness & dullness. Anti-fatigue fresh gel cream. For tired looking eyes Suitable for all skin types Results in percentages are as follows: 50% decrease in wrinkle depth
68% decrease in wrinkle density
24% decrease in wrinkle volume
45% decrease in dark circles
52% decrease in bags under eyes
62% smoothed contours around eyes
|
|
|
|
|
|
|
|
|
|
 |
